Annovis Bio

Annovis Bio, Inc. is a clinical stage drug platform company, which develops drugs to treat neurodegeneration. The firm compound is ANVS401, which is in Phase 2a clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, Alzheimer's disease in Down Syndrome, and other chronic neurodegenerative disorders. It also develops ANVS405 for protecting the brain after traumatic brain injury and/or stroke, and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia. The company was founded by Maria Luisa Maccecchini in May 2008 and is headquartered in Berwyn, PA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Annovis Bio, Inc. is a clinical stage drug platform company, which engages in the development of drugs which aim to treat neurodegenerative diseases such as Alzheimer's (AD) and Parkinson's (PD). Its lead product candidate, Buntanetap, is designed to address AD, PD, and potentially other chronic neurodegenerative diseases. Its product pipeline also includes ANVS405 and ANVS301, which focus on the treatment of traumatic brain injury, stroke, and advanced AD. The company was founded by Maria Luisa Maccecchini in May 2008 and is headquartered in Malvern, PA.

Radnor, Pennsylvania--(Newsfile Corp. - October 5, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds Annovis Bio, Inc. (NYSE American: ANVS) ("Annovis") investors that a securities fraud class action lawsuit has been on behalf of those who purchased or acquired Annovis securities between May 21, 2021 and July 28, 2021, inclusive (the "Class Period").Investor Deadline Reminder: Investors who purchased or acquired Annovis securities during the Class Period may, no...

Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Annovis Bio, Inc. - ANVS

HyreCar

Cassava Sciences Inc

NEW YORK, NY / ACCESSWIRE / October 5, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit.

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ANVS, SAVA and HYRE

NEW YORK, Oct. 4, 2021 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit filed on behalf of investors who purchased or acquired the securities of Annovis Bio, Inc.. ("Annovis Bio" or the "Company") (NYSE: ANVS) from May 21, 2021 through July 28, 2021 (the "Class Period").

ANVS SHAREHOLDER CLASS ACTION LAWSUIT DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Annovis Bio, Inc.

Los Angeles, California--(Newsfile Corp. - October 4, 2021) -  The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Annovis Bio, Inc. ("Annovis" or "the Company") (NYSE American: ANVS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between May 21, 2021 and July 28, 2021,...

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Annovis Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

RADNOR, Pa., Oct. 4, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that a securities fraud class action lawsuit has been filed against Annovis Bio, Inc. (NYSE: ANVS) ("Annovis") on behalf of those who purchased or acquired Annovis securities betweeen May 21, 2021 and July 28, 2021 , inclusive (the "Class Period").

ANVS Investor Reminder: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against Annovis Bio, Inc.

ATI Physical Therapy

Spectrum Pharma

NEW YORK, NY / ACCESSWIRE / October 3, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court.

CLASS ACTION UPDATE for ANVS, ATIP and SPPI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

New York, New York--(Newsfile Corp. - October 2, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Annovis Bio, Inc. (NYSE American:  ANVS) between May 21, 2021 and July 28, 2021, inclusive (the "Class Period"), of the important October 18, 2021 lead plaintiff deadline.SO WHAT: If you purchased Annovis Bio securities during the Class Period you may be entitled to compensation without payment of any...

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Annovis Bio, Inc. Investors with Losses to Secure Counsel Before Important October 18 Deadline in Securities Class Action - ANVS

Radnor, Pennsylvania--(Newsfile Corp. - October 2, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors of Annovis Bio, Inc. (NYSE American: ANVS) ("Annovis") that a securities fraud class action lawsuit has been filed on behalf of those who purchased or acquired Annovis securities between May 21, 2021 and July 28, 2021, inclusive (the "Class Period").Lead Plaintiff Deadline: October 18, 2021Website: https://www.ktmc.com/new-cases/annovis-bio-inc-anvs?utm_source=PR&utm_medium=link&utm_campaign=annovisContact: James Maro, Esq. (484) 270-1453Toll free (844) 887-9500

Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline for Securities Fraud Class Action Lawsuit Filed Against Annovis Bio, Inc.

New York, New York--(Newsfile Corp. - October 1, 2021) -  Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit filed on behalf of investors who purchased or acquired the securities of Annovis Bio, Inc.. ("Annovis Bio" or the "Company") (NYSE American: ANVS) from May 21, 2021 through July 28, 2021 (the "Class Period"). The lawsuit filed in the...

ANVS SHAREHOLDER CLASS ACTION DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Annovis Bio, Inc.

LOS ANGELES, Oct. 1, 2021 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Annovis Bio, Inc. ("Annovis" or the "Company") (NYSE: ANVS) securities between May 21, 2021 and July 28, 2021 , inclusive (the "Class Period").

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Annovis Bio, Inc. (ANVS) Investors

Royal Philips

Yalla Group

NEW YORK, NY / ACCESSWIRE / October 1, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

SHAREHOLDER ALERT: YALA PHG ANVS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Boston, Massachusetts--(Newsfile Corp. - September 29, 2021) - The Thornton Law Firm alerts investors who purchased Annovis Bio, Inc. securities (NYSE American: ANVS) between May 21, 2021 and July 28, 2021 may seek to participate in the case as a Lead Plaintiff. Interested investors may contact the Thornton Law Firm's investor protection team by visiting www.tenlaw.com/cases/Annovis for more information. Investors may also email investors@tenlaw.com or call 617-531-3917. A class action lawsuit has been filed on...

Annovis Bio Investor Alert: Shareholder Class Action Lawsuit Filed

Boston Beer Company

View

NEW YORK, NY / ACCESSWIRE / September 29, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment.

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ANVS, VIEW and SAM

NEW YORK, NY / ACCESSWIRE / September 29, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit.

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PHG, ANVS and ATIP

NEW YORK, NY / ACCESSWIRE / September 28, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment.

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of PHG, ANVS and SPPI

New York, New York--(Newsfile Corp. - September 26, 2021) - WHY:  Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Annovis Bio, Inc. (NYSE: ANVS) between May 21, 2021 and July 28, 2021, inclusive (the "Class Period"), of the important October 18, 2021 lead plaintiff deadline.SO WHAT: If you purchased Annovis Bio securities during the Class Period you may be entitled to compensation without payment of any out of...

Rosen, Global Investor Counsel, Encourages Annovis Bio, Inc. Investors with Losses to Secure Counsel Before Important October 18 Deadline in Securities Class Action - ANVS

Activision Blizzard

NEW YORK, NY / ACCESSWIRE / September 26, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment.

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ATVI, YALA and ANVS

SAN DIEGO, Sept. 25, 2021 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP announces that purchasers of Annovis Bio, Inc. ("Annovis" or the "Company") (NYSE: ANVS) between May 21, 2021 and July 28, 2021(the "Class Period") have until October 18, 2021, to file a lead plaintiff motion.

(ANVS) DEADLINE: Did You Suffer a Substantial Loss? Contact Johnson Fistel Regarding Leading Annovis Bio Class Action Lawsuit

NEW YORK, NY / ACCESSWIRE / September 24, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court.

LAWSUITS FILED AGAINST ANVS, HYRE and SPPI - Jakubowitz Law Pursues Shareholders Claims

Ardelyx

Oatly

NEW YORK, NY / ACCESSWIRE / September 24, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court.

CLASS ACTION UPDATE for OTLY, ARDX and ANVS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Radnor, Pennsylvania--(Newsfile Corp. - September 24, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that a securities fraud class action lawsuit has been filed against Annovis Bio, Inc. (NYSE American: ANVS) ("Annovis") on behalf of those who purchased or acquired Annovis securities betweeen May 21, 2021 and July 28, 2021, inclusive (the "Class Period").Investor Deadline Reminder: Investors who purchased or acquired Annovis securities during the Class Period...

Kessler Topaz Meltzer & Check, LLP: Reminds Investors of Securities Fraud Class Action Filed Against Annovis Bio, Inc.

Dr. Maria Maccecchini will present a corporate update on Tuesday, September 28 at 11:20am ETBerwyn, Pennsylvania--(Newsfile Corp. - September 24, 2021) - Annovis Bio, Inc. (NYSE American: ANVS) ("Annovis" or the "Company"), a clinical-stage drug platform company addressing Alzheimer's disease (AD), Parkinson's disease (PD) and other neurodegenerative diseases, today announced that Founder, President and CEO Maria Maccecchini, Ph.D. will present at the virtual Cantor Global Healthcare Conference to be held on September 27-30, 2021.The presentation will be available during a live webcast on Tuesday, September 28 at 11:20am ET,...

Annovis Bio to Present at the Cantor Global Healthcare Conference

Katapult Holdings

NEW YORK, NY / ACCESSWIRE / September 23, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly-traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment.

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of KPLT, ANVS and ATIP

NEW YORK, Sept. 23, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Annovis Bio, Inc. (NYSE: ANVS) between May 21, 2021 and July 28, 2021, inclusive (the "Class Period"), of the important October 18, 2021 lead plaintiff deadline.

ROSEN, A LEADING LAW FIRM, Encourages Annovis Bio, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important October 18 Deadline in Securities Class Action - ANVS

NEW YORK, NY / ACCESSWIRE / September 21, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit.

News for Annovis Bio Stock (ANVS)